Next-generation Sequencing Identified a Novel WDPCP-ALK Fusion Sensitive to Crizotinib in Lung Adenocarcinoma

被引：7
|
作者：
He, Zhen [1 ]
Wu, Xuan [1 ]
Ma, Shuxiang [1 ]
Zhang, Cuicui [1 ]
Zhang, Zhe [1 ]
Wang, Shuai [1 ]
Yu, Sheng [1 ]
Wang, Qiming [1 ]
机构：
[1] Zhengzhou Univ, Affiliated Canc Hosp, Henan Canc Hosp, Dept Internal Med, 127 Dong Ming Rd, Zhengzhou 450008, Henan, Peoples R China
来源：
CLINICAL LUNG CANCER | 2019年 / 20卷 / 05期
基金：
中国国家自然科学基金; 芬兰科学院;
关键词：
C1156Y; Crizotinib; Next-generation sequencing; Sensitivity; WDPCP-ALK; ANAPLASTIC LYMPHOMA KINASE; PATIENT; GENE; IMMUNOHISTOCHEMISTRY; CANCER;
D O I：
10.1016/j.cllc.2019.06.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E548 / E551
页数：4
相关论文
共 50 条
  • [1] SRBD1-ALK, a Novel ALK Fusion Gene Identified in an Adenocarcinoma Patient by Next-Generation Sequencing
    Hou, Xue
    Xu, Huamin
    Chen, Likun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (04) : E72 - E73
  • [2] ATAD2B-ALK, a Novel Fusion in Lung Adenocarcinoma Identified Using Next-Generation Sequencing (NGS)
    Bai, H.
    Jia, W.
    Jin, X.
    Mao, H.
    Wu, D.
    Chen, R.
    Xia, X.
    Wu, H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S844 - S844
  • [3] A novel 5′ALK fusion identified by next generation sequencing and validated by IHC in a patient with lung adenocarcinoma
    He, Zhengfu
    Zhu, Xingyu
    Zeng, Qingxin
    Yu, Zhaonan
    [J]. LUNG CANCER, 2021, 158 : 164 - 165
  • [4] PLB1-ALK: A novel head-to-head fusion gene identified by next-generation sequencing in a lung adenocarcinoma patient
    Wang, Bei
    Chen, Rongrong
    Wang, Changxi
    Chen, Huang
    Zhong, Dingrong
    [J]. LUNG CANCER, 2021, 153 : 176 - 178
  • [5] Next-Generation Sequencing Identified a Novel Crizotinib-Sensitive PLB1-ALK Rearrangement in Lung Large-Cell Neuroendocrine Carcinoma
    Wang, Shuai
    Wu, Xuan
    Zhao, Jiuzhou
    Chen, Haiyang
    Zhang, Zhe
    Wang, Mingyue
    Xu, Cong
    Wang, Yongsen
    Wang, Lili
    He, Zhen
    Wang, Qiming
    [J]. CLINICAL LUNG CANCER, 2021, 22 (03) : E366 - E370
  • [6] Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib: a case report
    Zhou, Yuling
    Lizaso, Analyn
    Mao, Xinru
    Yang, Nong
    Zhang, Yongchang
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (17)
  • [7] Identification of a Novel EML4-ALK, BCL11A-ALK Double-Fusion Variant in Lung Adenocarcinoma Using Next-Generation Sequencing and Response to Crizotinib
    Qin, Bao-Dong
    Jiao, Xiao-Dong
    Liu, Ke
    Wu, Ying
    Zang, Yuan-Sheng
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (06) : E115 - E117
  • [8] A Case of Lung Adenocarcinoma Harboring a Rare LOC285000-ALK-NCK2 Gene Fusion Identified by Next-Generation Sequencing With Long-Term Response to Crizotinib
    Zhang, Min
    Zhou, Huan
    Liu, Dan
    Yu, Ruoying
    Chen, Jun
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (02):
  • [9] VPS41-BRAF, a novel BRAF fusion gene identified in a lung adenocarcinoma patient by next-generation sequencing
    Wang, Lujuan
    Chen, Anqi
    She, Xiaoling
    Xiang, Juanjuan
    Tang, Jingqun
    [J]. LUNG CANCER, 2020, 146 : 380 - 381
  • [10] Genetic mutations in lung enteric adenocarcinoma identified using next-generation sequencing
    Lin, Li
    Zhuang, Wu
    Wang, Wenxian
    Xu, Chunwei
    Chen, Rongrong
    Guan, Yanfang
    Yi, Xin
    Shao, Yun
    Tai, Yanhong
    Chen, Yanping
    Wu, Meijuan
    Wei, Jianguo
    Chen, Gang
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (09): : 9583 - 9590
12345